2025 Expert Speaker Faculty

alessandro biffi -13th Alzheimer's & Parkinson's Drug Development Summit

Alessandro Biffi

Associate Vice President

Eli Lilly & Co.

andre matta - 13th Alzheimer's & Parkinson's Drug Development Summit

Andre Matta

Executive Director

Ventus Therapeutics

Andrew Kaplan - 13th Alzheimer's & Parkinson's Drug Development Summit

Andrew Kaplan

Principal Scientist

Bristol Myers Squibb

Andrew West - 13th Alzheimer's & Parkinson's Drug Development Summit

Andrew West

Professor of Neurobiology

Duke Center for Neurodegeneration & Neurotherapetics, Duke University

aparna vasanthakuma - 13th Alzheimer's & Parkinson's Drug Development Summitr

Aparna Vasanthakumar

Senior Principal Research Scientist

Abbvie

Ashley Bernardo - 13th Alzheimer's & Parkinson's Drug Development Summit

Ashley Bernardo

Scientific Director

Transpharmation™

Beth Hoffman - 13th Alzheimer's & Parkinson's Drug Development Summit

Beth Hoffman

CEO

Origami Therapeutics, Inc.

Sean Pintchovski - 13th Alzheimer's & Parkinson's Drug Development Summit

Bill shrader

cso

AcureX Therapeutics

Bruce Morimoto - 13th Alzheimer's & Parkinson's Drug Development Summit

Bruce Morimoto

Head, Drug Development

Fuku Biotech

carrie rubel - 13th Alzheimer's & Parkinson's Drug Development Summit

Carrie Rubel

Scientific Director - Biomarkers

Biogen

chloe whitehouse - 13th Alzheimer's & Parkinson's Drug Development Summit

Chloe Whitehouse

Senior Specialist, 3D Biofabrication

Merck & Co

Christopher Bunker 13th Alzheimer's & Parkinson's Drug Development Summit

Christopher Bunker

VP, Biopharma Bus. Dev.

Alamar Biosciences Inc.

christopher gibbons - 13th Alzheimer's & Parkinson's Drug Development Summit

Christopher Gibbons

Chief Scientific Officer & Co-Founder

CND Life Sciences

daniel klamer - 13th Alzheimer's & Parkinson's Drug Development Summit

Daniel Klamer

Vice President - Business Development & Scientific Strategy

Anavex

Dean Petkanas - 13th Alzheimer's & Parkinson's Drug Development Summit

Dean Petkanas

Co-Founder; Chairman & Chief Executive Officer

KannaLife Sciences Inc

Doo Yeon Kim - 13th Alzheimer's & Parkinson's Drug Development Summit

Doo Yeon Kim

Associate Professor of Neurology

Harvard Medical School

Edmond Teng

Senior Group Medical Director

Genentech

Elena Dale - 13th Alzheimer's & Parkinson's Drug Development Summit

Elena Dale

Executive Director, Neuroscience

Bristol Myers Squibb

Eric Siemers - 13th Alzheimer's & Parkinson's Drug Development Summit

Eric Siemers

Chief Medical Officer

Acumen Pharmaceuticals

Fabian Svara - 13th Alzheimer's & Parkinson's Drug Development Summit

Fabian Svara

Co-Founder & Chief Executive Officer

ariadne.ai ag

Fraser Bocell - 13th Alzheimer's & Parkinson's Drug Development Summit

Fraser Bocell

Senior COA Scientist

Critical Path Institute (C-Path)

Ginger-Johnson - 13th Alzheimer's & Parkinson's Drug Development Summit

Ginger Johnson

Senior Vice President, Strategy Consulting

Lumanity

Gül Erdemli- 13th Alzheimer's & Parkinson's Drug Development Summit

Gul Erdemli

Global Director, Program Regulatory

Novartis AG

Jackie Olley -Williams- 13th Alzheimer's & Parkinson's Drug Development Summit

Jackie Olley-Williams

Senior Scientist - Data

Eisai Co., Ltd.

Janaky Coomaraswamy -Williams- 13th Alzheimer's & Parkinson's Drug Development Summit

Janaky Coomaraswamy

Director, Neuroscience Translational Medicine

Takeda

Jonathan Brotchie

Chief Executive Officer & Chairman

Atuka

Kaare Bjerregaard-Andersen -Williams - 13th Alzheimer's & Parkinson's Drug Development Summit

Kaare Bjerregaard-Andersen

Principal Scientist

H. Lundbeck A/S

Katie Planey - 13th Alzheimer's & Parkinson's Drug Development Summit

Katie Planey

CEO

Acelot, Inc.

Kenneth Gregory Pugh - 13th Alzheimer's & Parkinson's Drug Development Summit

Kenneth Pugh

Geriatric Medicine Physician

Norton Healthcare

Luis Oliveira - 13th Alzheimer's & Parkinson's Drug Development Summit

Luis Oliveira

Senior Associate Director, Research Programs

Michael J. Fox Foundation

Manuela Polydoro - 13th Alzheimer's & Parkinson's Drug Development Summit

Manuela Polydoro

VP Head of Translational Medicine

Muna Therapeutics

Maria Maccecchini - 13th Alzheimer's & Parkinson's Drug Development Summit

Maria maccecchini

president & CEO

Annovis Bio

Melody Libby - 13th Alzheimer's & Parkinson's Drug Development Summit

Melody Libby

Alzheimer's & Pipeline Patient Advocacy Lead

Biogen

Michael Erkkinen - 13th Alzheimer's & Parkinson's Drug Development Summit

Michael Erkkinen

Instructor in Neurology

Brigham and Women's Hospital

Nadia Eckert - 13th Alzheimer's & Parkinsons Drug Development Summit

Nadia Eckert

Senior Director, R&D

Elixirgen Scientific

Natasha Penner Headshot - 13th Alzheimer's & Parkinsons Drug Development Summit

Natasha Penner

Senior Director, Head of Clinical Pharmacology

Eisai

neil cashman - 13th Alzheimer's & Parkinson's Drug Development Summit

Neil Cashman

Chief Scientific Officer & Co-Founder

ProMIS Neurosciences

Pallavi Sachdev - 13th Alzheimer's & Parkinson's Drug Development Summit

Pallavi Sachdev

Executive Director, Translational Medicine

Eisai Co., Ltd.

partick-howson - Atuka - 13th Alzheimer's & Parkinson's Drug Development Summit

Patrick Howson

Chief Innovation Officer

Atuka

paul edison - 13th Alzheimer's & Parkinson's Drug Development Summit

Paul Edison

Professor

Imperial College London

Paul Song - 13th Alzheimer's & Parkinson's Drug Development Summit

Paul Song

Chief Executive Officer & Chairman

NKGen Biotech

Peter DiBiaso - 13th Alzheimer's & Parkinson's Drug Development Summit

Peter DiBiaso

Patient

The Michael J. Fox Foundation for Parkinson's Research

Rebecca Edelmayer - 13th Alzheimer's & Parkinson's Drug Development Summit

Rebecca Edelmayer

Vice President, Scientific Engagement

Alzheimer's Association

Run Zhuang - 13th Alzheimer's & Parkinson's Drug Development Summit

Run Zhuang

Biostatistician

Unlearn.AI

Sandi See Tai - 13th Alzheimer's & Parkinson's Drug Development Summit

Sandi See Tai

Chief Development Officer

Lexeo Therapeutics

Sarah Veugelen - 13th Alzheimer's & Parkinsons Drug Development Summit

Sarah Veugelen

Managing Director & Senior Scientist - Neuroscience Research

Creative BioLabs

Sathya Ganesan - 13th Alzheimer's & Parkinson's Drug Development Summit

Sathya ganesan

Regulatory Science lead

UCB

Shane Hegarty - 13th Alzheimer's & Parkinson's Drug Development Summit

Shane Hegarty

Chief Scientific Officer & Co-Founder

Axonis Therapeutics

shannon leslie - 13th Alzheimer's & Parkinson's Drug Development Summit

Shannon Leslie

Senior Scientist

Johnson & Johnson

Spring Behrouz - 13th Alzheimer's & Parkinson's Drug Development Summit

Spring Behrouz

Chief Executive Officer

Vincere Biosciences

Steven Arnold- 13th Alzheimer's & Parkinson's Drug Development Summit

Steven Arnold

Director - Neurology ,Memory Disorders Unit Normal Pressure Hydrocephalus Program

Cardiovasuclar Genetics

Tammy Dellovade- 13th Alzheimer's & Parkinson's Drug Development Summit

Tammy Dellovade

Senior Research Fellow, Discovery Neuroscience

Abbvie

Tony Bannon - 13th Alzheimer's & Parkinson's Drug Development Summit

Tony Bannon

Senior Director - Scientific, Precision Medicine & Neuroscience

Abbvie

Tricia Thornton-Wells - 13th Alzheimer's & Parkinson's Drug Development Summit

Tricia Thornton-Wells

Sr Dir

Johnson & Johnson

Un Kang- 13th Alzheimer's & Parkinson's Drug Development Summit

Un Jung Kang

Founders Professor of Neurology

NYU Grossman School of Medicine

Urs Langen - 13th Alzheimer's & Parkinson's Drug Development Summit

Urs Langen

Lab Head & Research Project Leader

Roche

will shrader - 13th Alzheimer's & Parkinson's Drug Development Summit

William Shrader

CSO

AcureX Therapeutics

Xavier Langlois - 13th Alzheimer's & Parkinson's Drug Development Summit

Xavier Langlois

Head of Tau Pathobiology & Research Fellow

Abbvie

2025 EVENT GUIDE
REGISTER INTEREST
PRE-CONFERENCE DAY
BACK TO TOP